Virtus ETF Advisers LLC Gilead Sciences, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

A detailed history of Virtus ETF Advisers LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 5,182 shares of GILD stock, worth $465,136. This represents 0.21% of its overall portfolio holdings.

Number of Shares

5,182

Previous 5,182 -0.0%

Holding current value

$465,136

Previous $355,000 22.25%

% of portfolio

0.21%

Previous 0.18%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $33,027 - $38,116	523 Added 11.23%	5,182 $355,000
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $47,958 - $58,484	670 Added 16.8%	4,659 $341,000
Q4 2023 Feb 15, 2024	BUY	$73.27 - $83.09 $3,516 - $3,988	48 Added 1.22%	3,989 $323,000
Q3 2023 Nov 07, 2023	SELL	$73.94 - $80.67 $34,529 - $37,672	-467 Reduced 10.59%	3,941 $295,000
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $70,005 - $79,850	921 Added 26.41%	4,408 $339,000
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $4,947 - $5,637	64 Added 1.87%	3,487 $289,000
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $40,570 - $58,244	-651 Reduced 15.98%	3,423 $293,000
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $3,512 - $4,012	59 Added 1.47%	4,074 $251,000
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $72,669 - $81,847	-1,259 Reduced 23.87%	4,015 $248,000
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $93,167 - $105,747	-1,436 Reduced 21.4%	5,274 $383,000
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $41,697 - $44,986	-616 Reduced 8.41%	6,710 $469,000
Q2 2021 Aug 10, 2021	SELL	$63.47 - $69.35 $206,404 - $225,526	-3,252 Reduced 30.74%	7,326 $504,000
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $24,420 - $27,863	407 Added 4.0%	10,578 $684,000
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $123,440 - $140,654	2,179 Added 27.26%	10,171 $593,000
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $42,228 - $53,094	680 Added 9.3%	7,992 $505,000
Q2 2020 Aug 05, 2020	SELL	$72.34 - $84.0 $118,420 - $137,508	-1,637 Reduced 18.29%	7,312 $563,000
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $47,285 - $60,566	-755 Reduced 7.78%	8,949 $669,000
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $81,831 - $90,011	-1,328 Reduced 12.04%	9,704 $631,000
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $110,142 - $121,578	-1,762 Reduced 13.77%	11,032 $699,000
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $791,564 - $887,647	12,794 New	12,794 $864,000
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $602,351 - $674,791	-9,633 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$60.54 - $79.0 $112,120 - $146,308	-1,852 Reduced 16.13%	9,633 $603,000
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $52,818 - $58,479	741 Added 6.9%	11,485 $886,000
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $116,913 - $136,375	-1,802 Reduced 14.36%	10,744 $761,000
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $54,047 - $65,889	-742 Reduced 5.58%	12,546 $946,000
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $187,693 - $220,325	-2,638 Reduced 16.56%	13,288 $952,000
Q2 2017 Aug 14, 2017	BUY	N/A	15,926	15,926 $1.13 Million

Others Institutions Holding GILD

# of Institutions

1,924

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Gilead Sciences, Inc. Transaction History